Valuation: DiaSorin S.p.A.

Capitalization 4.1B 4.75B 3.82B 3.55B 6.61B 431B 7.12B 43.89B 17.31B 206B 17.83B 17.46B 751B P/E ratio 2025 *
22.1x
P/E ratio 2026 * 19.2x
Enterprise value 4.64B 5.38B 4.32B 4.02B 7.48B 488B 8.05B 49.64B 19.57B 233B 20.17B 19.75B 850B EV / Sales 2025 *
3.81x
EV / Sales 2026 * 3.46x
Free-Float
37.75%
Yield 2025 *
1.57%
Yield 2026 * 1.66%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.79%
1 week+2.81%
Current month+8.74%
1 month+18.26%
3 months-0.43%
6 months-15.85%
Current year+8.74%
More quotes
1 week 72.46
Extreme 72.46
77.64
1 month 62.64
Extreme 62.64
77.64
Current year 68.1
Extreme 68.1
77.64
1 year 58.18
Extreme 58.18
107.45
3 years 58.18
Extreme 58.18
131.4
5 years 58.18
Extreme 58.18
208.8
10 years 41.66
Extreme 41.66
211.8
More quotes
Manager TitleAgeSince
Chief Executive Officer 60 25/03/2007
Director of Finance/CFO 55 31/12/2015
Corporate Officer/Principal 62 28/04/2022
Director TitleAgeSince
Director/Board Member 60 27/04/2016
Director/Board Member 62 25/03/2007
Chairman 57 28/04/2022
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.79%+2.81%-25.75%-42.60% 4.76B
-1.51%-7.35%-4.82%+3.62% 14.56B
+0.03%+2.19%+201.74%+261.76% 14.43B
-0.79%-5.33% - - 7.65B
-0.12%-4.93%-4.06%+0.92% 6.56B
-1.36%-4.47%-29.53%+19.41% 4.34B
-0.40%+0.93%-8.14%-46.27% 3.04B
-2.83%+0.68%+36.51%-52.50% 2.68B
-1.23%+1.46%+4.97%-17.84% 2.54B
Average -1.11%-0.38%+21.36%+15.81% 6.73B
Weighted average by Cap. -0.89%-1.38%+50.07%+64.08%
See all sector performances

Financials

2025 *2026 *
Net sales 1.22B 1.41B 1.13B 1.05B 1.96B 128B 2.11B 13.01B 5.13B 61.01B 5.29B 5.18B 223B 1.29B 1.5B 1.2B 1.12B 2.08B 136B 2.24B 13.83B 5.45B 64.82B 5.62B 5.5B 237B
Net income 187M 217M 174M 162M 302M 19.69B 325M 2B 790M 9.39B 814M 797M 34.3B 217M 252M 202M 188M 350M 22.84B 377M 2.32B 916M 10.9B 944M 925M 39.79B
Net Debt 537M 623M 500M 466M 867M 56.53B 933M 5.75B 2.27B 26.97B 2.34B 2.29B 98.47B 374M 434M 349M 325M 604M 39.41B 650M 4.01B 1.58B 18.8B 1.63B 1.6B 68.64B
More financial data * Estimated data
Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2024, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.
Employees
3,242
More about the company
Date Price Change Volume
16/01/26 74.62 -1.79% 456,964
15/01/26 75.98 +0.58% 333,209
14/01/26 75.54 +0.91% 458,140
13/01/26 74.86 +1.93% 506,333
12/01/26 73.44 +1.18% 481,249

Real-time Borsa Italiana, January 16, 2026 at 04:45 pm

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
75.98EUR
Average target price
81.39EUR
Spread / Average Target
+7.12%
Consensus

Quarterly revenue - Rate of surprise